Search research articles
Contact Us
Filters
Showing results (41-50 of 188) with videos related to
Page
of 19
Sort By:
Australian and New Zealand Journal of Medicine
|
August 1, 1986
Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics
A Davis, R O Day, E J Begg
Nature
|
January 31, 1975
Nucleic acid-mutagen interactions: crystal structure of adenylyl-3',5'-uridine plus 9-aminoacridine
N C Seeman, R O Day, A Rich
British Journal of Clinical Pharmacology
|
May 13, 1998
Indicators for drug and therapeutics committees
L M Weekes, C Brooks, R O Day
Journal of Quality in Clinical Practice
|
March 30, 1999
Towards the safer use of non-steroidal anti-inflammatory drugs
R O Day, D Rowett, E E Roughead
Anaesthesia and Intensive Care
|
July 27, 2016
Evaluation of hospital-wide computerised decision support in an intensive care unit: an observational study
W Santucci, R O Day, M T Baysari
Drug Safety
|
February 1, 1993
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance
A G Johnson, P Seideman, R O Day
The Medical Journal of Australia
|
April 7, 1997
Toxicity of antirheumatic drugs
T Lehmann, R O Day, P M Brooks
The Journal of Rheumatology
|
November 1, 1993
Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study
S E Tett, R O Day, D J Cutler
The Medical Journal of Australia
|
August 2, 1993
Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs?
T V Kot, R O Day, P M Brooks
Journal of Pharmaceutical Sciences
|
February 1, 1992
Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques
S E Tett, D J Cutler, R O Day
Page
of 19
Search research articles
Search
Showing results (41-50 of 188) with videos related to
Sort By:
Page
of 19
Australian and New Zealand Journal of Medicine
|
August 1, 1986
Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics
A Davis, R O Day, E J Begg
Nature
|
January 31, 1975
Nucleic acid-mutagen interactions: crystal structure of adenylyl-3',5'-uridine plus 9-aminoacridine
N C Seeman, R O Day, A Rich
British Journal of Clinical Pharmacology
|
May 13, 1998
Indicators for drug and therapeutics committees
L M Weekes, C Brooks, R O Day
Journal of Quality in Clinical Practice
|
March 30, 1999
Towards the safer use of non-steroidal anti-inflammatory drugs
R O Day, D Rowett, E E Roughead
Anaesthesia and Intensive Care
|
July 27, 2016
Evaluation of hospital-wide computerised decision support in an intensive care unit: an observational study
W Santucci, R O Day, M T Baysari
Drug Safety
|
February 1, 1993
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance
A G Johnson, P Seideman, R O Day
The Medical Journal of Australia
|
April 7, 1997
Toxicity of antirheumatic drugs
T Lehmann, R O Day, P M Brooks
The Journal of Rheumatology
|
November 1, 1993
Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study
S E Tett, R O Day, D J Cutler
The Medical Journal of Australia
|
August 2, 1993
Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs?
T V Kot, R O Day, P M Brooks
Journal of Pharmaceutical Sciences
|
February 1, 1992
Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques
S E Tett, D J Cutler, R O Day
Page
of 19